Corbus Pharmaceuticals Holdings Inc. is a clinical-stage pharmaceutical company focused on developing new treatments for cancer and obesity. Its product pipeline includes an antibody-drug conjugate targeting cancer cells, a tumor growth inhibitor, and an oral treatment for obesity. The company operates through rigorous clinical trials and is committed to advancing evidence-based therapies that address significant health challenges. Corbus is based in the United States and emphasizes a patient-first approach in its research and development efforts.
